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ABSTRACT 
Of the 2.87 million traumatic brain injuries (TBI) sustained yearly in the United States, 75% are 
diffuse injuries. A single TBI can have acute and chronic influences on the neuroendocrine 
system leading to hypothalamic-pituitary-adrenal axis (HPA) dysregulation and increased 
affective disorders. Preliminary data indicate TBI causes neuroinflammation in the hippocampus, 
likely due to axonal damage, and in the paraventricular nucleus of the hypothalamus (PVN), 
where no axonal damage is apparent. Mechanisms regulating neuroinflammation in the PVN are 
unknown.  Furthermore, chronic stress causes HPA dysregulation and glucocorticoid receptor 
(GR)-mediated neuroinflammation in the PVN.  The goal of this project was to evaluate 
neuroinflammation in the HPA axis and determine if GR levels change at 7 days post-injury (DPI). 
 
Adult male and female Sprague Dawley rats were subjected to midline fluid percussion injury. At 
7 DPI, half of each brain was post-fixed for immunohistochemistry (IBA-1) and half biopsied for 
gene/protein analysis. IBA-1 staining was analyzed for microglia activation via skeleton analysis 
in the hypothalamus and hippocampus. Extracted RNA and protein were used to quantify mRNA 
expression and protein levels for GRs. Data indicate increased microglia cell number and 
decreased endpoints/cell and process length in the PVN of males, but not females. In the dentate 
gyrus, both males and females have an increased microglia cell number after TBI, but there is 
also an interaction between sex and injury in microglia presentation, where males exhibit a more 
robust effect than females. Both sexes have significant decreases of endpoints/cell and process 
length. In both regions, GR protein levels decreased for injured males, but in the hippocampus, 
GR levels increased for injured females. Data indicate that diffuse TBI causes alterations in 
microglia morphology and GR levels in the hypothalamus and hippocampus at 7 DPI, providing a 
potential mechanism for HPA axis dysregulation at a sub-acute time point.  
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1.0 INTRODUCTION: TRAUMATIC BRAIN INJURY 
1.1 Epidemiology of a Traumatic Brain Injury 
There are 2.87 million reported traumatic brain injuries (TBI) every year in the United States. Of 
these, over 75% include diffuse axonal injury (DAI)1, 2. Yet, the true incidence of TBI is unknown 
as many do not seek medical care. According to the National Women’s Health Network, it is 
estimated that overall 20 million women have sustained at least one TBI from domestic violence 
in the United States - exceeding the numbers for athletes and military combined3. As a result, TBI 
has been carrying the moniker of a “silent epidemic.” TBI has been indicated in chronic 
neurological and endocrine dysregulation, for which there are limited treatment options.  
 
According to the Center for Disease and Control (CDC), falls accounted for 48% of all reported 
TBIs, followed by “being struck by or on the head”, motor vehicle accidents, and reported 
assaults2. Children ages 0-4 and older adults over 75 years of age have the highest rates for TBI-
related ER visits 2. As such, TBI carriers a wide economic burden, costing the United States 
approximately $48.3 billion dollars annually in ongoing medical, socioeconomic (disability 
payments/vocational rehab), and lost wage costs4. There is a 12-70% chance of TBI survivors 
returning of work, dependent upon injury severity 5. The World Health Organization predicts that 
by 2020, TBI will be the third leading cause of death and disability in the world6, 7, leading to an 
even greater economic burden.  
 
1.2 Diffuse Axonal Injury is Characterized by Axonal Shearing 
There are three main types of TBIs – focal, diffuse, and blast – each characterized by the 
hallmarks of the injury. Focal injury is characterized by an injury in a localized part of the brain8; 
blast injury is brain trauma characterized by three main effects: shockwaves, shrapnel, and 
acceleration/deceleration9. Lastly, diffuse traumatic brain injury (dTBI) is characterized by rapid 
acceleration and deceleration of the head8 often with side-to-side head rotation, which leads to 
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DAI. The hallmark pathology of DAI is axonal shearing and tearing10, causing disruptive circuits, 
thus leading to a secondary injury cascade and subsequent post-concussive symptoms (PCS)11. 
 
1.3. Brain Injury Leads to Post-Concussive Symptoms 
Roughly 20% of TBI survivors report PCS after one month of recovery, and 15% continue to 
report persisting or permanent symptoms. PCS are typically categorized into three categories: 
somatic, affective, and cognitive which include symptoms such as headaches or migraines, 
seizures, neuro-ocular dysfunctions, depression, memory problems, dizziness, fatigue, and 
anxiety12-16. Table 1 provides a more comprehensive, but not complete list of the symptoms within 
these categories.  
 
Somatic Cognitive Affective 
Endocrine dysfunction Inability to concentrate Anxiety 
Speech changes Communication problems Depression 
Headaches/migraines Memory problems Mood swings 
Loss of motor skills Inability to plan Impulsivity 
Seizures Impaired problem solving Apathy 
Visual issues Difficulty processing Disinhibition 
Sleep changes  Aggression 
Problems with coordination  Impaired social skills 
Stress disorders  Stress disorders 
Table 1 Post-Concussive Symptoms 
Stress disorders and other endocrine-related symptoms are interspersed throughout the PCS list 
as the hypothalamic-pituitary-adrenal (HPA) axis is particularly susceptible to damage from 
primary and secondary injury. After injury, there is an initial, short-lived cortisol (CORT) surge 
followed by a drawn-out decrease, causing dysregulation the HPA axis17. Damage to or 
dysregulation of the HPA axis leads to increased affective disorders (up to 50% of survivors) and 
to endocrinopathies (between 30-50% of survivors)18. 
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1.4 TBI is a Diseased State 
1.4.1 Every TBI is Initiated by a Mechanical Event 
Every TBI begins with mechanical forces initiating the primary injury. Such damages are 
irreversible and are only amenable to prevention. The primary injury is considered to be the 
damage that occurs during the moment of the event, including cell damage or loss, axonal 
shearing or tearing, broken synapses, subarachnoid hemorrhage, contusion, epidural or subdural 
hematoma, neurovascular damage, and blood-brain-barrier breakdown16, 19, 20. Primary injury 
leads to a secondary injury cascade which can last for days to weeks to months to years19.  
 
1.4.2 The Primary Injury Leads to a Secondary Injury Cascade 
Secondary signaling continues over the ensuing days to weeks in an attempt to restore 
homeostasis in injured tissue, which, if not controlled, can exacerbate the injury4. Cellular and 
humoral inflammation are principle among the responses and a hallmark of both clinical and 
experimental brain injury. Post-traumatic responses are communicated by robust increases in 
pro- and anti-inflammatory cytokines, which are below detectable levels in healthy tissue21, 22. 
Cytokines induce structural and functional changes in the resident central nervous system (CNS) 
cells, particularly microglia. Primarily, microglia remove cellular debris to attenuate inflammatory 
processes and promote tissue remodeling23, 24. At the same time, activated microglia release 
neurotoxic substances (e.g., free radicals, glutamate) that can exacerbate injury. Therefore, 
neuroinflammation is currently viewed as a double-edged sword with the potential to both 
promote and/or repair injury25.  
 
2.0 MICROGLIA  
2.1 Microglia are the Brain’s Resident Immune Cells 
Microglia are the brain’s resident immune cells. Microglia are a type of neuroglia found throughout 
the CNS26 comprising of about 10-15% of all cells in the brain27. The primary duty of microglia is 
to remove cellular debris and promote tissue remodeling 23, 24; however, different morphologies of 
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microglia have specific and designated functions 28, 29. Microglia are typically described in one of 
six morphologies: ramified, hyper-ramified/bushy, activated, amoeboid, rod, or dystrophic 30-32, 33. 
 
2.2 Microglia Activate Following Injury  
The morphology of a microglia cell reflects its function11-12,33. Figure 1 is a representative image 
that depicts the typical morphologies of microglia33: Under normal physiological conditions, 
ramified (resting) microglia have a small cell body with fine, long processes (Fig. 1A). Ramified 
microglia continually survey the CNS and respond to stimuli to maintain homeostasis13-15. When 
ramified microglia encounter a stimulus, it will activate, proliferate, and migrate to the site of 
injury. Hyper-ramified microglia retract and thicken their processes, creating a “bushy” like 
appearance (Fig. 1B). Hyper-ramified and activated morphologies initiate either neurotoxic or 
neurotrophic signaling, depending on the nature of the stimulus16 with continued signaling through 
fractalkines, glycoproteins, and cytokines34. Activated morphologies retract and thicken their 
processes even more (Fig. 1C). Activated morphologies are presumed to secrete cytokines and 
migrate to sites of injury11,12. Amoeboid microglia are fully activated, are indistinguishable from 
infiltrating macrophages (fully retracted processes), and function to phagocytose cellular 
debris9,11-12 (Fig. 1D). Rod microglia are elongated, polarized, and morphologically distinguishable 
from other forms of microglia 31, 35 (Fig. 1E). The distinct rod microglia morphologies have been 
identified in numerous disease states 31, 35-50. Although most of their function remains unclear, it is 
proposed that rod microglia act as scaffolding to axons and dendrites to the injured, ailing, or 
aging brain as they consistently align themselves with injured neurons51.  
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Figure 1 Representative Figure Depicting the Most Common Microglia Morphologies Following Injury 
(Ziebell et.al, 2016). 
Lastly, dystrophic (senescent) microglia are termed to be “diseased” microglia as they cannot 
respond to any stimulus as their processes are beaded, fragmented, and twisted. Dystrophic 
microglia are typically found in the aging brain, but have appeared after experimental brain injury 
in non-aged adult mice52, 53. See Streit et.al, 2009 for images and characteristic information.  
 
2.2 Microglia Can Be Detected by Several Different Markers 
Microglia are typically detected by the ionized calcium binding adaptor molecule-1 (IBA-1) marker 
for general inflammatory investigation, however, they can also be detected by the fractalkine 
receptor CX3CR1. Additionally, different morphologies of microglia can be detected by different 
markers. For instance, MHCII+ and CD80+ identify activated microglia54, CD86+ identifies 
amoeboid microglia55, and CD45low identifies ramified microglia. Additionally, F4/80 and CD14 
markers distinguish infiltrating macrophages/monocytes from resident microglia56, 57. Lastly, the 
dystrophic morphology has a phenotype all of their own with increased microglia expression of IL-
1α, HLA-DR, and MHCII 32. 
 
2.3 Microglia are Usually Found in Areas of Neuropathology 
Neuroinflammation and neuropathology tend to overlap after injury. Neuropathology, defined for 
the scope of this study and for evaluation of TBI, is dead or dying neurons typically evaluated by 
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silver staining58. When a ramified microglia encounters debris, it proliferates, differentiates, and 
migrates to the site of injury33. Proliferation and migration increases the microglia cell number; 
differentiation causes microglia endpoints/cell and process length to decrease, indicating 
microglial activation59, 60. Activated microglia are critical for cleaning up the debris after neuronal 
death.  
 
3.0 Neuropathology is Not the Only Trigger for Altered Microglia Presentation 
Neuroinflammation also occurs when an animal or human is exposed to stress61. In different 
studies, rodents that undergo differing stress paradigms see an increase in microglia number and 
activation and an increase in proinflammatory cytokines62-64. 
 In a restraint stress mouse model, after 4 days of exposure to stress, whole brain flow cytometry 
indicated elevated levels of microglia cell number65. In a repeated social defeat mouse model, 
microglia cell numbers and activation increased in the paraventricular nucleus (PVN) of the 
hypothalamus and the amygdala. When coupled with varied unpredictable stress, repeated social 
stress increases microglia cell numbers and activation in the hippocampus62.  
 
In a chronic mild stress model, proinflammatory cytokines were elevated in the cortex (TNF-a/IL-
10) and hypothalamus (TNF-a/IL-10, IL-6/IL-10) in males66. In females, restraint stress increased 
circulating IL-6 after two weeks of prolonged stress. In the cortex, IFN-g and TNF-a were 
increased; in the hippocampus, IFN-g was increased67.  
 
There is limited information about sex differences in stressed animals and microglia presentation 
in the HPA axis. In the hippocampus, amygdala, and prefrontal cortex, unstressed females had a 
higher activated to ramified ratio than unstressed males. However, when females were exposed 
to stress, activated microglia in the prefrontal cortex decreased. Additionally, microglia in females 
had increased expression of CX3CR1 fractalkine receptors but decreased MHCII and CD4068. In 
a sex-differences study looking at 1 (acute) and 10-day (chronic) restraint stress outcomes, male 
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and females had several regional differences in the orbitofrontal cortex, amygdala, and 
hippocampus.  In the hippocampus, male activation decreased acutely and chronically.  There 
were no significant differences in microglia presentation or activation for females. Acutely CD40 
and CX3CL1 expression increased in females while chronically CD40, iNOS, CX3CL1, and 
CD200 increased in males69. In the hypothalamus, acute restraint stress activated more CRH-
producing neurons in female rats than in male rats, which could lead to increased levels of CORT 
production70.  
 
Microglia express glucocorticoid receptors (GR) on their surface, therefore, the drastic increase of 
the stress hormone, cortisol (CORT), may affect the microglia’s response62. However, to fully 
understand the dynamics, the circuitry behind the HPA axis and its relationship with inflammation 
must first be explored.  
 
4.0 THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS  
4.1 The Hypothalamus Maintains a Homeostatic State 
The hypothalamus is located inferior to the thalamus and is comprised of several nuclei, each 
specializing in a particular function. The hypothalamus receives neural information from several 
different areas in the brain – including the spinal cord, the amygdala, the hippocampus, and the 
prefrontal cortex. The hypothalamus is responsible for keeping the body at homeostasis. The 
hypothalamus is comprised of several specific nuclei all designed to regulate specific functions 
geared towards maintaining homeostasis: growth, temperature control, metabolism and body 
weight, fear and anger responses, circadian rhythm, reproduction, fluid balances, hunger, thirst, 
sexual arousal, aggression, regulates calcium balance, respiratory control, immune system 
influences through the thymus, and stress response regulation71, 72.  
 
The vascular of the hypothalamus is critical as the hypothalamus sends and receives information 
by hormones – which travel through the circulatory system. The hypothalamus receives its blood 
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supply from the circle of Willis, which branches into an eventual fenestrated capillary network. 
Additionally, the hypothalamus lies above a venous circle, providing drainage for several smaller 
vein73. The hypophyseal portal system is a circulatory system of blood vessels that connects the 
hypothalamus and anterior pituitary. This system contains several fenestrated capillary networks 
enabling the exchange of hormones, particularly growth hormone releasing hormone, thyrotropin-
releasing hormone, and corticotropin-releasing hormone (CRH)74. However, these fenestrated 
capillary networks leave the hypothalamus vulnerable to damage by large molecules that cannot 
cross the blood brain barrier (BBB) at other locations75, 76.  
 
The PVN is a specialized nucleus in the hypothalamus that regulates the stress response. It is 
responsible for synthesizing a 41-amino acid peptide, CRH, which is released in the presence of 
a stimulus. CRH travels through fenestrated capillaries of the hypophyseal portal system to the 
anterior pituitary and binds to the CRH receptor, a G-protein coupled receptor, initiating 
intracellular signaling to stimulate the release of adrenocorticotropic hormone (ACTH)77.  
 
4.2 The Pituitary Gland is Known as the “Master Gland” 
The pituitary gland is attached to the base of the hypothalamus and has been dubbed “the master 
gland” because its hormones cause a neuroendocrine cascade influencing other regions, 
particularly the thyroid gland, adrenal gland, ovaries, and testes to synthesize and release 
hormones of their own. The hypothalamus sends signals to the pituitary gland to either inhibit to 
release pituitary hormones71, 78. 
 
The pituitary is divided into two parts: the anterior pituitary and the posterior pituitary. The anterior 
pituitary gland, also known as the adenohypophysis, is the glandular part of the pituitary and 
mediates many processes including stress, growth, reproduction and lactation by synthesizing 
and releasing specialized hormones: ACTH, thyroid-stimulating hormone (TSH), follicle-stimulate 
hormone (FSH), luteinizing hormone (LH), prolactin, and growth hormone (GH). The posterior 
pituitary gland, or neurohypophysis, is comprised of neural tissue and axons of neurons whose 
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cell bodies reside in the supraoptic nucleus and PVN. These projections stem from the PVN, run 
through the infundibulum, and terminate into the posterior pituitary to release hormones oxytocin 
and vasopressin71, 78.  
 
In the anterior pituitary, CRH stimulates ACTH release. ACTH is formed from 
proopiomelanocortin (POMC), a 241 amino acid protein. POMC undergoes several cleavages, 
yielding many peptides, including ACTH, a 39 amino acid peptide. ACTH travels through systemic 
circulation to the adrenal gland and binds to G protein-coupled receptors in the fasciculata and 
reticularis zone of the adrenal cortex79.  
 
4.3 The Adrenals Release Corticosterone  
The adrenal glands are located superior and medial to the superior pole of each kidney. Each 
adrenal gland is divided into the cortex and the medulla. The adrenal cortex consists of three 
distinct layers: the glomerulosa (15% of the cortex), the fasciculata (75% of the cortex), and the 
reticularis (10% of the cortex). ACTH initiates the production of cortisol (CORT) in humans 
(corticosterone in rats), which is released within minutes of a stimulus80 – a fact that drives 
translational research methodology when measuring CORT.  
 
4.4 The Hippocampus Provides Primarily Inhibitory Signals to the HPA Axis 
The hippocampus is a part of the limbic system and is well known for its role in memory and 
learning; however, it also has a lesser-known, yet equally critical role in HPA axis regulation. In 
humans, the hippocampus is located under the cerebral cortex in the medial temporal lobe. In 
rats, the hippocampus is located at the dorsal part of the brain. Moving posteriorly, the CA1 forms 
dorsal horns that wrap laterally around the brain on either side. Additionally, Ammon's Horn 
(pyramidal layers), otherwise known as the “hippocampus proper”, and the dentate gyrus (granule 
layer) structures look like two interlocking “Cs”.  
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There are several subsections to the hippocampus including the CA1-4 and the dentate gyrus. 
Each subsection has differing inputs and outputs and thus different roles. The hippocampus, 
including the dentate gyrus, is inhibitory to the HPA axis in circadian and stressed conditions by 
way of negative feedback when subjected to CORT81. The dentate gyrus has the highest 
concentration of GRs in comparison to the rest of the hippocampus, suggesting a more integral 
role in the regulation of the HPA axis82, 83.  
 
Neuronal death and atrophy of the hippocampus cause an increase in CORT production84, 85.  
This is important to note as the hippocampus is susceptible to neuronal damage after DAI86, 
where the degree of injury correlates to the degree of atrophy87, 88. 
 
4.5 The HPA Axis Circuit Is Regulated by Negative and Positive Feedback Loops 
The HPA axis is a highly-regulated circuit between the hypothalamus, the pituitary gland, and the 
adrenal glands. Indirect interactions with the hippocampus, amygdala, and prefrontal cortex also 
play a pivotal role in regulation. This system sends and receives communication - both neurally 
and hormonally - and is the primary system for stress regulation89. Stress can stimulate CRH into 
blood from the PVN. CRH then travels to and stimulates the anterior pituitary which releases 
ACTH into the blood which binds to the receptors on the adrenal glands and stimulates the 
release of CORT. Differential regulation can occur because MRs and GRs are not co-localized 90. 
When CORT binds to GRs or MRs in the hippocampus, it initiates a positive and negative 
feedback loop respectively91. However, the hippocampus’ primary purpose is to inhibit the release 
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Figure 2 Schematic of CORT Regulation by The HPA Axis. The PVN Releases Corticotropin-Releasing 
Hormone (CRH). CRH Travels to The Anterior Pituitary and Triggers Release of Adrenocorticotropic 
Hormone (ACTH), Which Travels Through the Blood Stream to the Adrenal Cortex on Top of The Kidneys. 
ACTH Stimulates the Release of Cortisol/Corticosterone (CORT). CORT Circulates in the Blood and Travels 
to the Anterior Pituitary, Binds to Glucocorticoid Receptors (GR) And Through Negative Feedback 
Mechanisms, Slows the Production Of ACTH. CORT Also Travels to the PVN And to the Hippocampus, 
Binds to Grs and Mineralocorticoid Receptors (MR) and Slows the Production of CRH by Way of Negative 
Feedback. There is Some Positive Feedback Through Indirect Hippocampal-Hypothalamic Signaling, 
However, the Hippocampal-Hypothalamic Signals are Mostly Inhibitory.  
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4.6 CORT Follows a Diurnal Rhythm That Can Be Disrupted 
ACTH and CORT follow a diurnal rhythm controlled by the suprachiasmatic nucleus of the 
hypothalamus. In humans, both hormones peak in the early morning followed by a slow descent 
until reaching the nadir at approximately midnight. ACTH and CORT increase slowly after the 
nadir, and just before peaking, increase abruptly, simulating a hormone surge80, 93. ACTH typically 
peaks between 4:00AM and 6:00AM, whereas CORT peaks at approximately 8:00AM80. As rats 
are nocturnal animals, their diurnal rhythm of ACTH and CORT is reversed; under normal light 
conditions, ACTH and CORT are peaked in the evening, not the morning93. 
 
Sometimes the diurnal cycle becomes unbalanced. Trauma – including blood loss, surgery, 
infection, and stress – can increase the secretion of ACTH and CORT into the blood as well as 
contribute to increased inflammation. Activated microglia -the hallmark of neuroinflammation- 
release proinflammatory cytokines including IL-1, IL-6, IL-2, and TNF-α 94, 95. IL-1 and IL-6 
stimulate the release of CRH from the hypothalamus, which in turn stimulates the release of 
ACTH and eventually, CORT. IL-2 and TNF-α can stimulate the release of ACTH from the 
pituitary, thus stimulating the release of CORT96.  
 
4.7 CORT Binds to the Adrenoreceptors 
There are two types of adrenocorticoid receptors, type I (MR) and type II (GR). While both 
receptors bind CORT, each differ in structure, function, and concentration levels throughout brain 
regions. MR’s are composed of 984 amino acids while the two main isoforms of GR’s, GRα and 
GRβ are composed of 777 and 742 amino acids, respectively97. CORT has a higher affinity for 
MR’s, thus saturating MR’s before binding to GR’s. CORT’s affinity for each receptor parallels 
with the receptor’s functions: MR’s are tasked with several different functions that are considered 
to be proactive, maintaining a basal HPA homeostatic state, including diurnal rhythms, while also 
binding aldosterone, a mineralocorticoid that plays a critical role in regulating the cell 
concentration of sodium and potassium by stimulating the transcription for sodium-potassium 
pumps98. When CORT binds to MR’s, it creates proactive feedback to maintain basal HPA axis 
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activity. Once all MR’s are saturated, CORT will bind to GR’s which are reactive in functioning – 
responding to increased CORT from stress or stimulus exposure and providing negative feedback 
to slow down production of CRH and ACTH.  
 
GRs and MRs are both expressed on microglia, however, the two receptors are not always co-
localized99. GR’s have the highest expression in the PVN, then the dentate gyrus, the CA1 of the 
hippocampus respectively, and finally the central and cortical amygdala. MR’s have the highest 
expression in the hippocampus100.  
 
4.8 Cortisol is the Main Glucocorticoid 
CORT is the main glucocorticoid and is produced by the adrenal cortex of the adrenal gland. 
Although CORT is involved in the regulation of energy, immune reactions, and most notably, the 
stress response, the cellular targets and mechanisms of CORT are largely unknown. CORT binds 
to both MRs - influence proactive feedback in order to maintain basal HPA axis activity- and GRs 
– which regulates the reactive feedback of the HPA axis in response to stress. There is evidence 
that TBI is capable of influencing gene expression, protein levels, and signaling of  both 
receptors101-103.  
 
4.9 CORT Can Be Proinflammatory 
The production of CORT can either inhibit inflammation, under low level stress conditions, or 
activate inflammation responses under chronic, intense levels of stress104, 105..CORT’s classic 
anti-inflammatory response inhibits MHCII expression, thus disabling dendritic cells from 
interacting with immature T-cells while also promoting the expression of anti-inflammatory 
cytokines (IL-10, TGF- β) and restricting the expression of pro-inflammatory cytokines (IL-1β, IL-
6, TNF-α)106. Alternate studies have shown that exposure to stress, after LPS injection, increases 
TNF-α63, MHCII107, F4/8065, and activates microglia63, 107. Additionally, in a restraint-stress mouse 
model, after exposure to 15 hours of restraint stress for 4 days, serum CORT levels in mice 
significantly increased and microglia cell counts in the brain significantly increased65. Increased 
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stress, and thus CORT levels, reflect increased activity of NFκB and expression of NFκB target 
genes106. Furthermore, exogenous CORT administration can also up-regulate Toll-like Receptor 
2/4 (TLR2/4)40 which increases microglia activation41.  
 
4.10 CORT is Influenced by the Estrous Cycle 
Additionally, circulating CORT is different amongst males and females while also indicating a 
plausible relationship with the estrous cycle in females. Circulating CORT levels increase at the 
peak times of estrus and proestrous rats; nadir levels remain unchanged108. In cholinergic 
stimulation, females in proestrous and estrus have a higher ACTH and CORT response than 
females in diestrous or metestrous. Males had a higher ACTH and CORT response than the 
females after stimulation, but females in all cycle stages had higher baseline levels of ACTH and 
CORT than males109. In males and estrus females, there was a minimal slope in the 
concentration of plasma CORT per unit concentration of immunoreactive ACTH, however, the 
slope reached its maximum for rats in proestrous110.  
 
5.0 THE HPA AXIS AND TBI 
5.1 THE HPA AXIS is Highly Susceptible to Primary Injury 
The anatomical location the pituitary gland, stalk, and the hypothalamus makes the HPA axis 
highly susceptible to damage after DAI111. The rapid acceleration or deceleration of the head can 
injure the pituitary by fracturing the bony sella or shearing the pituitary stalk, effectively disrupting 
the circuits of the axis112. Additionally, as there is much vascular in and around the hypothalamus 
and pituitary, DAI can cause direct damage to the hypophyseal portal veins which supplies blood 
to the pituitary causing possible infarction or hypoxia. Additionally, due to fenestrated capillaries, 
the hypothalamus is also vulnerable to damage by circulating molecules that cannot cross the 
BBB in other locations75, 76. 
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5.2 Secondary Injury of the HPA Axis Leads to Dysfunction 
As mentioned earlier, the HPA axis is particularly susceptible to damage from secondary injury 
contributing to increased affective disorders and to endocrinopathies18. TBI is one of the leading 
causes of hypopituitarism – the severity of the hormonal dysfunction correlating to the severity of 
the injury113. In one-third of autopsy reports, pituitary necrosis was documented114. Gonadotropin 
and GH are the two most common disrupted hormones after TBI113, 115, however recent studies 
have indicated that TBI may disrupt vasopressin release, inciting diabetes insipidus development 
among survivors116. Data describing prognosis is conflicting, with some studies describing that 
symptoms improve over time and others describing that symptoms will worsen overtime117, 118.  
 
6.0 EXPERIMENTAL INJURY 
6.1 There are Several Models of Experimental Injury 
Rodent models are a useful tool to replicate symptoms, understand mechanisms, and develop 
treatments for TBI as the physiological circuitry is translational to humans. There are several 
experimental injury models, each designed to mimic a type of brain injury and the injury’s 
pathology. For example, controlled cortical impact (CCI) and weight drop for focal injury119, blast 
simulators and blast overpressure for blast injury120, 121, and fluid percussion for diffuse injury122, 
123.  
 
6.2 Midline Fluid Percussion Injury is a Clinically Relevant Model 
There are multiple variations to the fluid percussion injury model (FPI): lateral, parasagittal, and 
midline. Each of these variations were designed to develop unique pathology and 
symptomatology at the acute and chronic time points88. The lateral FPI model produces a more 
focal-type injury and the parasagittal FPI model produces a focal and diffuse injury. The midline 
FPI (mFPI) model chosen for these experiments produces a theoretical evenly distributed 
bilateral diffuse injury23, 88, 122. However, mFPI is heterogeneous as there is neuronal death next to 
healthy tissue with some areas being affected more than others when evaluated by silver stain. 
Regardless, mFPI is a clinically relevant model of dTBI as it is the most translational of the three 
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variations of FPI models with over 30 years of implementation and supporting literature. See 
Lifshitz et. al, 2016 for more information on clinical relevance.  
 
6.3 Midline Fluid Percussion Injury 
To deliver a mFPI, a craniectomy is performed 
along the sagittal suture, approximately half-way 
between bregma and lambda. Then, a pendulum 
is dropped from a pre-determined height that 
delivers a single fluid pulse through a fluid-filled 
chamber over the dura, producing a bilateral 
diffuse injury without cavitation or contusion88, 122. 
Determinants of injury severity for mFPI include 
the fencing response and righting reflex time. The fencing response is a lateral or bilateral 
forearm posturing upon the moment of impact that is proposed to coincide with neurochemical 
and pathological cascades in the lateral vestibular nucleus of the brainstem. In the mFPI model, 
100% of rats fence88, 122, 124. The righting reflex time is the second determinant of injury severity. 
After impact, the rat is laid supine on its back and its suppression of reflexes is timed. The timer is 
stopped when the rat rights itself. The righting reflex time correlates to injury severity: the longer it 
takes for the rat to right, the more severe the injury. For this study, all animals fell between a 6-
12-minute righting reflex time (average RR time) which is indicative of a mild-moderate injury.  
 
6.4 Histopathology and Neuropathology of mFPI 
The mFPI model reproduces many of the expected results of human dTBI including metabolic 
dysregulation, hypotension, and subdural hematoma125. Additionally, mFPI induces a 
histopathological state similar to concussion particularly in regions of greatest strain, such as 
blood vessels, neuronal processes and at gray-white matter interfaces123, 126-128. Astrocytes - 
whose main function is neuronal maintenance, synapse formation, and extracellular formation - 
react and proliferate after mFPI for up to 28 DPI129, 130. In response to mFPI, microglia react in a 
Figure 3 FPI Device. An Implanted Cranial Hub is Attached 
to the Injury Device Where an Adjustable Pendulum Falls 
and Strikes the Plunger, Generating a Fluid Pulse That 
Impacts the Dural Surface, Resulting in a DAI Without 
Cavitation or Contusion 
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highly coordinated time-course consisting of pro- and anti-inflammatory cytokines, chemokines, 
and reactive oxygen species33. 
 
Neuropathology has been identified chronically up to 28 DPI, occurred primarily in the sensory 
barrel fields of the cortex and lateral sections of the midbrain, specifically ventral thalamus and 
the CA3 of the hippocampus131. Additionally, dentate gyrus becomes excitable, likely contributing 
to seizure disorders and cognitive deficiencies132. The proximity of these regions to the temporal 
ridge makes them particularly susceptible to damage by mFPI (Lifshitz et al., in preparation).  
 
6.5 Motor and Cognitive Deficits From mFPI 
Specifically, mFPI results in morbidities related to: motor performance using rotarod and beam 
walk on days 1-5 following injury133, post-injury learning using the Morris water maze (MWM) 1-2 
weeks following injury134, late-onset sensory hypersensitivity using the whisker nuisance task 
(WNT) 135, and anxiety-like behavior using the open field test130. As such, mFPI results in a 
reproducible, clinically relevant model of dTBI.  
 
6.6 Limits of mFPI 
In humans, TBIs are like fingerprints – each unique and distinct to the individual and no two 
exactly alike - even though there are some similarities and overlap. Contrary to initial assumption, 
a harder impact does not always equate to a more severe injury or increased number of 
symptoms136, 137. In mFPI, this variability is difficult to replicate as mFPI is performed under 
controlled conditions. mFPI surgical procedures creates a craniectomy on the midline of the skull, 
which releases cranial pressure upon impact; in humans and rats, elevated intracranial pressure 
after TBI is associated to increased deficits and prolonged or more severe symptoms138-140. While 
mFPI is a great translational and clinically replicable model, sleep disorders, vestibular 
symptoms, migraines, and deficits among females have not been replicated or measured in this 
model, yet88.  
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7.0 SEXUAL DIFFERENCES  
7.1 Sexual Differences in Physiology and Anatomy 
The gonadal hormonal differences between males and females can influence several 
downstream effects. While males and females both have testosterone, estrogen, and 
progesterone, the levels for the hormones vary depending on sex: males have higher 
testosterone; females have higher estrogen and progesterone141. Males and females have some 
anatomical differences in the brain, many of these differences in specific nuclei of the 
hypothalamus and the medial nucleus of the amygdala142. Additionally, there are many 
neurochemical differences between the sexes. Males and females differ in their levels of 
norepinephrine, serotonin, vasopressin, acetylcholine, and dopamine142. In humans, females tend 
to have less neck muscles than men, leading to a lower neck to head strength ratio and creating 
an opportunity for an increase in acceleration at the neck at the time of impact143. In rats, females 
generally tend to weigh less than their male age-matched counterpart144. Our laboratory has also 
noted that a female Sprague Dawley’s skull is much thinner than an age-matched male. Weight 
and skull thickness must be taken into consideration when conducting mFPI, as the females will 
need to be hit at a lower atmospheres of pressure (atm) to equate the same injury severity as the 
males (calculated by righting reflex time and survival rate as a function of atm carried out in both 
male and female rats).  
 
7.2 Female Estrous Cycle 
Females have four different stages of estrous - proestrus, estrus, metestrus, and diestrus, each 
characterized by differing hormone levels and differing vaginal cells that can be analyzed by 
vaginal swabbing or flush. Humans and rats’ cycles are not identical. Humans have a 28-day 
cycle. The LH surge occurs around day 14-15 of the cycle. Estrogen and FSH are peaked at the 
same time as the LH surge and progesterone peaks about 5-6 days later. Female rats have a 4.8 
day cycle average145. Estrogen peaks just before the near-simultaneous LH surge, progesterone, 
and FSH peaks146. While a limitation of these studies was that estrous was not tracked, the 
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influence of the estrous cycle and its influence is critical for determining the role of gonadal 
hormones, PCS, and HPA axis dysregulation.  
 
 7.3 Sexual Differences in TBI 
The research studying sexual differences in TBI is limited and data conflicts147-149, likely due to 
variables of estrous/menstruation at the time of injury, which must be taken into consideration150. 
Furthermore, research assessing the differences in outcomes between women in different stages 
of estrous/menstruation is even less conclusive150, 151. In addition to higher rates of loss of 
consciousness152, several studies report that women of child-bearing age are more likely to have 
continuing symptoms of anxiety and depression after mild TBI147, 153-156. Recent data suggest that 
in sports with similar rules, women athletes sustain more concussions than men athletes. 
Likewise, women athletes experience or report a higher number of concussions, increased 
severity of symptoms, and report a longer duration of recovery than men athletes157-159. As 
previously stated, cycle at the time of injury is an import factor of injury outcome. Women in their 
high-progesterone luteal phase when sustaining a TBI showed significantly worse outcomes, 
including quality of life and neurological functioning in comparison to women in the follicular 
phase or who took oral contraceptives150. When compared with controls, women with TBI have an 
increased risk of giving birth to a stillborn, more severe postpartum depression, lower mental 
health, increased number of abnormal papsmears, and increased problems with menstrual 
cycles160. In experimental models of TBI, anxiety and depression have also been identified161. 
 
8.0 PREVIOUS STUDIES 
There are changes in microglia cell number after TBI in the PVN overtime. Skeleton Analysis (SA) 
was conducted on sham, 1, 2, and 7 male Sprague Dawley rats by taking six 40x images of the 
PVN per animal using standard protocol through ImageJ. Data were analyzed and summarized. 
Data showed a decrease in microglia cell number at 1 and 2 DPI in comparison to sham animals, 
which was not expected. There was an increase at 7 DPI in comparison to 2 DPI. There was no 
significant difference in endpoints or in branch length (Fig 4). These data indicate the microglia cell 
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counts change over time, indicating some influence of TBI on microglia in the PVN in the absence 
of neuropathology or astrocytosis.162 The endpoint data was used to conduct a power calculation 





There are changes in glucocorticoid receptor gene expression after TBI in the pre-optic 
hypothalamus over time in males. Our laboratory previously used real-time (RT) qPCR to analyze 
gene expression in GRs in Sprague Dawley rats on sham and at 1, 3, 5, and 7 DPI. Gene 
expression for GRs changed significantly over time F(1, 12)=4.6; p=0.015), first increasing at 5 DPI 
and then significantly decreasing between 5 and 7 DPI indicating a disruption in the HPA axis after 
TBI, albeit there was no significant difference between 7 DPI and sham (Fig 5).  
 
 
At 7 DPI significance is not reached between CORT levels in male sham and injured rats. In 
these experiments, terminal trunk blood from live decapitated rats was collected between 8-10AM 
and centrifuged to separate plasma from red blood cells (RBCs). CORT was quantified in plasma 
samples (diluted 1:50) using ELISA kits. Due to variability in sham animals CORT did not reach 
Figure 5 Glucocorticoid Relative Gene Expression in the 
Pre-Optic Hypothalamus in Males. Relative Gene 
Expression of Glucocorticoid Receptors Was Significantly 
Decreased Between 5 DPI and 7 DPI ($P<0.05 Between 
5 And 7 DPI).  
Figure 4 Preliminary Data of Skeleton Analysis of Microglia Changes in the PVN. Skeleton Analysis Was 
Conducted at Sham, 1, 2, And 7 DPI in the PVN. A) The Number of Microglia Significantly Decreased at 1 
and 2 DPI Compared to Sham. Microglia Cell Number Significantly Increased From 2 DPI to 7 DPI. B) 
There Were No Significant Differences in Average Number of and Points Per Microglia. C) There Were 
No Significant Differences Between Average Lengths of Branches Per Microglia.  
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significance in males (Fig 6). Animal numbers are being increased due to variability for each 
group.  
 
At 2 months post-TBI, basal/resting levels of CORT are lower than sham and blunted response to 
restraint stress indicates CORT dysregulation. In these experiments, baseline tail vein blood was 
taken prior to surgery for all rats between 8-10AM and centrifuged to separate plasma from RBCs. 
CORT was quantified in plasma samples (diluted 1:50) using ELISA kits. Then at 2 months post-
injury, injured and sham rats were placed in a cylindrical restrainer tightly for 30 minutes and then 
loosened. Blood was taken by tail vein at 0, 30, 60, and 90 minutes. These results indicate that TBI 















9.0 SCOPE OF THE PROJECT AND HYPOTHESIS 
Our laboratory’s preliminary data have indicated changes in microglia cell number in the PVN 
across time with a peak at 7 DPI in comparison to other times points and with a significant 
* 
Figure 6 Circulating Corticosterone 
Levels in Males (A) and Females 
(B) at 7 DPI. 
Figure 8 At 2 Months Post-Injury, There 
is HPA Axis Dysregulation as Indicated 
by Blunted CORT Response in Injured 
Rats (Rowe et. al, 2016) 
Figure 7  At 2 Months Post-Injury, CORT 
Levels Are Significant Decreased 
Compared to Compared to Baseline 
Levels and Compared to Sham Rats 
(Rowe et. al, 2016) 
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decrease in cell number at 1 and 2 DPI in comparison to sham. Our laboratory’s preliminary data 
have also shown that after dTBI, GR gene expression changes over time and it coincides with 
microglia presentation. GRs are present on microglia (and other cell types) and have been 
indicated to regulate microglial proliferation, differentiation, and activation state 163-165.These data 
indicate that TBI has some influence over microglia in the PVN. Previous studies have shown 
drastic differences in neuroinflammation between males and females after focal TBI where males 
were more likely to have increased neuroinflammation at several DPI, yet no studies have 
investigated these changes in dTBI166, 167. Additionally, in mouse restraint stress models, stress 
incites CORT dysregulation, microglia activation, and proinflammatory cytokine release155. The 
purpose of this project was to evaluate neuroinflammation in an area with no quantifiable 
neuropathology and an area with neuropathology in the HPA axis and determine if GR levels 
were changing in those regions, providing evidence that GR expression may be driving microglial 
activation after TBI. Therefore, these experiments were designed to test the hypothesis that 
diffuse experimental TBI incites sexual differences in the HPA axis, influencing 
hypothalamic and hippocampal microglia presentation as well as glucocorticoid receptor 




For these experiments, previously collected tissue was utilized from, young, adult, age-
matched, male and female Sprague-Dawley rats (9-12 weeks old when ordered; 300-350 g vs 
200-250 g). Rats were pair housed in a 12-hour light/12-hour dark cycle (6:00/18:00) at a 
constant temperature (23°C ± 2° C) with food and water ad libitum. Rats acclimated to the 
environment for at least three days before surgery.  
9.2 Midline Fluid Percussion Injury 
Rats were randomized into sham or brain-injured groups and were prepared for sham surgery or 
mFPI to induce a 6-12 minute righting reflex time using previously published methods161, 168 .  
 
  23 
Rats were anesthetized using 5.0% isoflurane (3L/minute oxygen) and then were maintained 
during surgery using 2.5% isoflurane (3L/minute oxygen). Rats were placed on a heating pad 
during and immediately following surgery to maintain body temperature. In a stereotaxic frame, a 
midline scalp incision exposes the skull and then 4.8mm craniotomy was made positioned on the 
sagittal suture halfway between bregma and lambda without disrupting the underlying dura mater. 
The injury hub – which was created prior to surgery from the female end of a Luer-lok – was then 
set on the craniotomy site and secured using glue and dental acrylic. Rats were returned to a 
warmed holding cage and monitored until injury induction (about 90 minutes) at which time they 
were re-anesthetized using 5% isoflurane. The injury-hub assembly was filled with physiological 
saline and attached to the male end of the fluid percussion device (Custom Design and 
Fabrication, Virginia Commonwealth University, Richmond, VA). As the rat’s reflexive responses 
return, a moderate injury (1.8- 2.1atm) was administered by releasing the pendulum onto the 
fluid-filled cylinder. Rats were monitored for the return of the righting reflex. Sham rats were 
connected to the FPI device, but the pendulum was not released. The injury-hub assembly was 
removed en bloc, integrity of the dura observed, and bleeding controlled prior to the incision being 
stapled. Lidocaine and bacitracin were applied to the incision site. After injury, animals were 
monitored for apnea, return of righting reflex, and presence of the fencing response.169 Inclusion 
criterion for the injury group included a righting reflex time of 6-12 minutes and a fencing 
response169 (>90% occurrence). Rats had post-ops for at least 3 days’ post-surgery. Rats that lost 
10% or more body weight in the first 3 days’ post-injury were excluded from the study (<5% 
occurrence).  
 
Discomfort, distress, pain, and injury were limited to that which is unavoidable in the conduct of 
scientifically sound research. Injured rats were monitored for three days post-injury for signs 
indicative of distress: lack of activity, vocalizations, lack of appetite, dehydration, excessive 
weight loss, and excessive gnawing or scratching at the injury site. Any rats demonstrating 
persistent visible signs of pain, distress or discomfort (vocalizations, absence of eating or 
drinking, etc.) were immediately euthanized (<5% occurrence). Typically, rats subjected to these 
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procedures in our laboratory recover, eat, drink, and show no outward signs of pain or distress. 
Post-surgery analgesics are not given for pain management aside from topical lidocaine as they 
can alter functional and pathophysiological outcomes of the injury, thus skewing results170. Rats 
were assessed for their post-operative condition at 1-3 hours and 24 hours after injury and daily 
thereafter. Post-operative reports noting locomotion, behavior, and appearance of incision site 
were recorded.  
 
9.3 Live Decapitations and Dissections 
At 7 DPI, between 8:00 and 10:00AM, rats were prepared for live decapitation, trunk blood 
collection, organ, and brain dissections. Rats were taken from the home room and the home cage 
was temporarily held outside of the necropsy room while the first rat was anesthetized. Rats were 
live decapitated with a two-minute delay. Rats were anesthetized with 5.0% isoflurane (3L/minute 
oxygen) for 2.0 minutes. Rats were measured from the tip of the nose to the base of the tail, 
weighed, and then immediately decapitated. Trunk blood was centrifuged to separate plasma 
from RBCs. Adrenal glands, kidneys, ovaries, testes, thyroids, and pituitaries were harvested and 
weighed. Brains were harvested and halved. One half of each brain was post-fixed in 4% 
paraformaldehyde for immunohistochemistry analysis. The other half was dissected using a 
chilled rat brain matrix. Coronal sections were 2mm apart and tissue biopsies were 2mm in 
diameter. Brain regions includes the hypothalamus, hippocampus, amygdala, thalamus, striatum, 
cortex, ventral tegmental area, and nucleus acumens. Plasma was stored in -20 °C. Half brains 
were sent to Neuroscience Associates in Knoxville, TN for professional IBA-1 staining. Brain 
biopsies were stored in -80 °C.  
 
The original study was designed to have multiple samples across time at 7, 56, and 168 DPI. 
However, some of these samples were stored incorrectly. Trial experiments were performed to 
test the viability of the samples. All 7 DPI samples were stored correctly. See Appendix B for 
further details.  
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9.4 Skeleton Analysis Quantifies Microglia 
SA is the only method available to quantify microglia morphologies. SA demonstrates the 
required sensitivity to identify small changes in microglia ramification status among experimental 
groups. It is flexible and adaptable to: whole image or single cell analysis, high or low 
magnifications, and immunofluorescence or non-fluorescence immunohistochemistry protocols59, 
60. Lastly, this analysis method uses readily available software (ImageJ).  
 
SA performs 3 quantifications on photomicrographs of labeled microglia: 1) number of soma/cell 
bodies, 2) number of processes, and 3) summed length of processes. From these numbers, we 
can quantify the average number of processes per cell and the length of processes per cell. To 
quantify population morphology, a previously published ImageJ based SA protocol will be used. 
SA uses a 1-pixel wide backbone of an image and provides relevant data such as the number of 
microglia processes and process length that reflect cell ramification. Photomicrographs will be 
prepared for skeletal analysis using plugins, available in ImageJ (unsharp mask filter, 
thresholding, and remove outliers), in order to visualize all microglia processes. Image processing 
protocols were pre-determined and remained consistent for all image processing. Resulting 
images were converted to binary, skeletonized, and the number of processes per skeleton, and 
the branch lengths are then generated by the Skeletonize (2D/3D) plugin, and summarized or 
averaged, respectively59, 60.  
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Figure 9 Representative Images of the ImageJ Conversation From an Original IBA-1 Image to a Binary and 
Finally to a Skeletonized Image (Morrison et.al, 2017) 
 
Figure 10 Representative Images of Skeletonized Microglia Being Converted Into a Quantifiable Form 
Where Processes (Orange), Junctions (Purple) and Endpoints (Blue) Are Differentiated (Morrison et.al, 
2017).  
 
9.5 RNA and Protein Extraction 
An optimized Qiagen Total All-Prep (catalog # 80004) protocol was used to extract RNA and 
protein from hypothalamus and hippocampal biopsies. Biopsies were homogenized in 600mL of a 
1:100 ratio BME: Buffer RLT ratio using a FisherBrand Pellet Pestle mixer for 3 minutes. Lysate 
was centrifuged at 4°C for 3 minutes at full speed before the supernatant was transferred to an 
AllPrep DNA spin column and centrifuged again for 30 seconds at 8000g. The flow-through was 
combined with 100% ethanol and mixed well. The new mixture was transferred into a RNeasy 
spin column and centrifuged for 20 seconds at 8000g. The flow-through was poured into a new 
2ml tube and placed on ice for protein purification. Several buffer washes were added to the 
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RNeasy spin column: Buffer RW1, Buffer RPE, and 80% EtOH. The RNeasy spin column was 
then centrifuged at full speed for 5 minutes to dry before adding 30μl of RNase-free water and 
centrifuging again at 8000g for 1 minute to elute the RNA. See Appendix A for the full optimized 
protocol. 
 
RNA purity and quality were immediately checked (Nanodrop, Thermo-Scientific 2000) by the 
260/280nm absorbance ratio. Quantity of RNA (ng/μl) was also checked and recorded. All RNA 
was within the established range of purity (1.9-2.1) and were at least 25ng/μl. RNA was stored at 
-80°C. 
 
Buffer APP was added to the “protein” flow-through, mixed vigorously, and incubated at room 
temperature for 10 minutes before being centrifuged for 10 minutes at full speed. The supernatant 
was decanted and 500μl of 70% ethanol was added. The tubes were centrifuged for 1 minute at 
full speed, then all liquid was decanted, and the protein pellet was left to dry for at least 10 
minutes. The protein pellet was resuspended in SDS and incubated for 5 minutes at 95°C to 
completed dissolve and denature the protein. Protein concentrations were determined using the 
Bicinchoninic acid assay (BCA) using manufactures instructions (Pierce, Rockford, IL). Protein 
was stored at -80°C.  
 
9.6 Quantitative RT qPCR 
Total RNA was converted to cDNA using the High Capacity RNA-to-cDNA Kit from Life 
Technologies™ (catalog # 4387406), then diluted to 5ng for RT qPCR use. Applied Biosystems 
TaqMan® Gene Expression Assays for GR (Rn00561369_m1) and CRH (Rn00578611_m1) were 
evaluated. Assays were run in multiplex along with a biological control of Eukaryotic 18S 
ribosomal RNA (rRNA) (4310893E) and the TaqMan® Fast Advanced Master Mix (catalog # 
4444963) in a ratio of 9μl of master mix: 1μl of gene: 1μl 18s rRNA per well. Samples were run in 
triplicate. TaqMan® Fast Advanced Master Mix thermocycling protocols were used. Eukaryotic 
18S rRNA was used as a biological control as it shows less variance in expression across a 
  28 
variety of treatment conditions than β-actin or GAPDH in addition to quick amplification. See 
Appendix C for sample plate design.  
 
For relative gene expression analysis, each sample was normalized to the 18S rRNA biological 
control and then to gene expression levels in the sham group using the 2-ΔΔCT method171.  
 
9.7 Automated Capillary Western –ProteinSimple (Wes) 
The Automated Capillary Western (Wes) by ProteinSimple ® is an advanced technology that can 
analyze up to 25 samples of proteins by size from 2-440 kDa using 0.5-5 µg of protein in 
approximately 3-4 hours. Through this novel technology, small tissue biopsies (2x2mm) from 
discrete brain regions can be used to perform multiple assays. This enables more specific nuclei 
to be assessed, albeit with some error relevant to the size of the nuclei within hypothalamus and 
hippocampus. The associated software, Compass (ProteinSimple®), provides results that are 
quantifiable and reliable172. Further technical properties are described by Rustandi et. al, 2012 
and Loughney et. al, 2014. 
 
Protein expression was evaluated using the Wes. The primary antibodies and plate conditions are 
listed in Table 2. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the 
biological control for the Wes as it is dispersed throughout the brain, albeit with some variability. 
Our laboratory conducted several optimizations with different biological controls, including β-actin, 
and due to the properties of the Wes, including chance of chemiluminescence blow out, GAPDH 
was the most accurate control for these experiments. 
 
Secondary antibodies, streptavidin HRP, dithiothreitol (DTT), molecular weight fluorescent 
standards (internal control), luminol, hydrogen peroxide, sample buffer, antibody diluent, running 
buffer, wash buffer, capillaries and plates (stacking matrix, separation matrix, wash buffer, matrix 
removal buffer) were purchased from ProteinSimple (Santa Clara, CA). The Simple WesternTM 
was also purchased from ProteinSimple.  
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Rabbit AbClonal, A2164 
 
37°C X 30 
mins 
0.25 1/50 GAPDH 
 GAPDH Mouse Novus, NB600-502   1/50  
Table 2 Simple Western Plate Properties 
Following protein concentration determination by BCA assay, samples were prepared according 
to the manufacturer’s recommendations. Samples were combined with sample buffer and master-
mix (40mM DTT, 0.1x ProteinSimple Sample Buffer, and 1x Fluorescent Standards) to achieve 
the desired concentration. Samples were then denatured via heating block at 37°C for 30 
minutes. The ladder, samples, primary and HRP-conjugated secondary antibody, wash buffer, 
antibody diluent and chemiluminescent were then placed in the designated wells per 
experimental design. Each plate was centrifuged at 2500 RPM for 5 minutes and placed into the 
automated capillary western machine where proteins were separated by size (electrophoresis), 
immobilized and immunoprobed in individual capillaries. Once loaded into the instrument, the 
following metrics were utilized for separation and detection: Separation matrix loading time 200 
seconds, stacking matrix loading time 15 seconds, sample loading time 9 seconds, separation 
time 25 minutes at 375V. After separation, samples are the exposed to UV light for 4sec and 
capillaries are immobilized for 200 seconds to allow for cross-linking between the sample and 
wall of the capillary. The matrix is removed with matrix removal buffer and 3 consecutive wash 
buffer cycles. Sample were then blocked with antibody diluent for 5 min followed by primary 
antibody (incubation times indicated in Table 1). Secondary antibodies were incubated for 30 
minutes followed by detection with chemiluminescence (luminol/ hydrogen peroxide solution). 
Capillaries were then imaged at the following times: 5, 15, 30, 60, 120, 240 and 480 seconds.  
 
Each sample is run in duplicate. To lessen variability, the same sham samples are run on every 
plate, in addition to a positive control from another cohort. See Appendix D as a sample plate 
design. For analysis, Compass (ProteinSimple®) generates an electropherogram containing 
peaks that correspond to the expression of all proteins of interest, including a peak for the 
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biological control protein (see Figure 12). The area under the curve (AUC) is calculated for each 
peak. To calculate relative protein expression, the AUC for the protein of interest is divided by the 
AUC for the biological control protein for all samples. All sham samples are averaged then each 






9.8 Statistical Analysis 
For statistical analysis, the primary outcome measure was to compare sham rats to injured rats in 
each sex (Student’s t-test). The secondary outcome measure was to measure sex differences 
between sham (Student’s t-test). The tertiary outcome measure was to assess for interactions 
between injury and sex using a two-way ANOVA with a Fisher’s LSD post-hoc comparison. All 
bar graphs represent the mean ± SEM, where *p<0.05 unless otherwise specified. For unequal 
Figure 11 Sample of the Electropherogram Generated by Compass (ProteinSimple®) for Target Protein Analysis. 
The Biological Control, GAPHD, is at 42 kDa, While the Target Protein, NC3R1 (GR), is Known to be Around 103 
kDa.  
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variance, we used non-parametric equivalents. All statistical analyses were performed using 
Prism 7 (Graph Pad, La Jolla, CA). 
 
10.0 RESULTS 
10.1 Skeleton Analysis of Microglia  
dTBI results in neuroinflammation, as indicated by cell number increase, endpoint decrease, and 
branch length decrease – which is supported by our preliminary data. As such, the hypothesis for 
these experiments was cell numbers for males would be increased in both the PVN (a region with 
no pathology) and the dentate gyrus (a region with overt pathology), but endpoints and branch 
length would decrease. Female microglia presentation for the PVN is unknown, but per Villapol 
et. al, 2017, female microglia presentation is expected to be increased after injury in the dentate 
gyrus, but less so than males166. 
 
In the PVN, the average microglia cell numbers were significantly increased at 7 DPI in males but 
not in females (t8=5.797), p=0.001; n=5. The number of microglia process endpoints per cell were 
significantly decreased at 7 DPI in males but not in females in the hypothalamus (t8= 2.480), 
p=0.038; n=5. There were no significant differences in process branch length for males or 
females in the hypothalamus. The endpoint data from this cohort was used to conduct a power 
calculation and 80% power was achieved with n=5. 
 
In the dentate gyrus, the average of microglia cell numbers was significantly increased at 7 DPI in 
males (t8= 7.717), p<0.001 and in females (t8= 2.754), p=0.025 compared to respective shams 
(n=5/group). There was a robust interaction between sex and injury for microglia cell number 
(F(1,16)=16.60, p<0.001). Post-hoc analysis with an uncorrected Fisher’s LSD revealed a 
significant decrease in microglia cell number between injured males and injured females (t16= 
4.955, p<0.001. The number of microglia process endpoints per cell were significantly decreased 
at 7 DPI in males (t8= 4.020, p=0.004) and in females (t8= 2.635, p=0.029) compared to 
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respective shams. There was a significant decrease in process branch length in males (t8= 3.417, 
p=0.009) and females (t8= 3.726, p=0.006)  
 
My hypothesis was supported for males and females in both the hypothalamus and dentate 
gyrus. These data indicate that microglia morphology is significantly altered in males, not 
females, in the hypothalamus at 7 DPI. In the hippocampus, TBI induced a robust response in 
cells, branch length and endpoints in both males and female, however, there was a significant 




Figure 12 Representative 40x Images Showing IBA-1 Stained Microglia in the PVN. The Top 2 Panels are 
Representative Images of Male Sham (Left) and Male Injured (Right). The Bottom 2 Panels are 
Representative Images of Female Sham (Left) and Female Injured (Right).  





























Figure 13 A) The Average of Microglia Cell Numbers Was Significantly Increased at 7 
DPI in Males but Not in Females in the PVN (n=5). B) The Number of Microglia Process 
Endpoints Per Cell Were Significantly Decreased At 7 DPI in Males but Not in Females 
in the Hypothalamus (n=5). C) There Were No Significant Differences in Process Branch 
Length for Males or Females in the Hypothalamus (n=5) Bars Represent the 
Mean±SEM, *P<0.05.  















Figure 14 Representative 40x Images Showing IBA-1 Stained Microglia in the Dentate Gyrus. The Top 2 
Panels are Representative Images of Male Sham (Left) and Male Injured (Right). The Bottom 2 Panels are 
Representative Images of Female Sham (Left) and Female Injured (Right). 
































Figure 15 A) The Average of Microglia Cell Numbers Was Significantly Increased at 7 
DPI in Males (*p<0.05; n=5) and in Females ($p<0.05; n=5) Compared to Respective 
Shams in the Dentate Gyrus. Additionally, There is a Significant Decrease in Microglia 
Cell Number Between Injured Males and Injured Females in the Hippocampus 
(#p<0.05; n=5). There Was an Interaction Between Sex and Injury. B) The Number of 
Microglia Process Endpoints Per Cell Were Significantly Decreased at 7 DPI in Males 
(*p<0.05; n=5) and in Females ($p<0.05; n=5) Compared to Respective Shams in the 
Hippocampus. C) There was a Significant Decrease in Process Branch Length in Males 
(*p<0.05; n=5) and Females ($p<0.05; n=5) in the Hippocampus. Bars Represent the 
Mean±SEM. 
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10.2 Gene Expression of Glucocorticoid Receptors  
 
In these experiments, relative gene expression of GRs from extracted hypothalamus and anterior 
hippocampus were quantified. GR’s have a lower affinity for CORT but are present in higher 
quantities. CORT only binds to GR’s when there is an overabundance, inciting pathways to bring 
CORT levels back to homeostatic levels. Based on the preliminary data for GR expression in 
males, we hypothesized that GRs would be decreased at 7 DPI in both the hypothalamus and 
hippocampus. Based on the high variability of plasma CORT levels in injured females vs. injured 
males we predict more variability in females.  
 
In the hypothalamus, significance for GR gene expression was not reached in males (t10=1.220, 
p=0.218; n=5-7). There were no significant differences in GR gene expression in females 
(t10=0.356, p=0.729; n=4-8). In the hippocampus, significance for GR gene expression was not 




Figure 16 A) Significance is Not Reached for GR Gene Expression Between Sham and Injured Males and 
There are No Significant Differences for GR Gene Expression Between Sham and Injured Females. (n=4-8). 
B) Significance is Not Reached for GR Gene Expression in Males or Females Between Sham and Injured 
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10.3 Protein Expression of Glucocorticoid Receptors  
Our laboratory’s preliminary data indicated that relative GR gene expression was significantly 
increased at 5 DPI but significantly decreased at 7 DPI in comparison to sham. We hypothesized 
that in both regions, the hypothalamus and hippocampus, protein expression would be decreased 
in comparison to sham at 7 DPI in males. Female expression was unknown.  
 
In the hypothalamus, injured males were significantly decreased in GR protein expression 
compared to sham males (t10= 3.397, p=0.007; n=5-7), however, injured females were 
significantly increased in GR protein expression (t12= 2.562, p=0.025; n=5-9). When comparing 
GR expression of sham males to GR expression of sham females, significance was not reached 
(t7= 1.371, p=0.213; n=4-5). In the hippocampus, injured males had a significant decrease in GR 
protein expression compared to sham males (t10= 2.977, p=0.014; n=4-8). There were no 
significant differences between sham females and injured females (t11= 0.817, p=0.436; n=4-9). 
When comparing GR expression of sham males to GR expression of sham females, sham males 
expressed significantly more GR than sham females (t6= 6.552, p=0.001; n=4).  
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Figure 17 Glucocorticoid Protein Expression in the Hypothalamus and Hippocampus. A) and B) In the 
Hypothalamus, There Was Significant Decrease in GR Gene Expression in Males (N=5-7) Yet Significant 
Increase in GR Expression in Females (n=5-9). C) Significance Was Not Reached Between Hypothalamus 
Sham Male and Sham Female GR Expression (n=4-5). D) and E) In the Hippocampus, There Was 
Significance Decrease in GR Gene Expression in Males (n =4-8), But No Significant Differences in Females. 
F) In the Hippocampus, Sham Females Expressed Significantly Less GR Protein Expression Than Sham 
Males (n=4). Bars Represent the Mean±SEM. *P<0.05 
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10.4 Gene Expression of Corticotrophin-Releasing Hormone  
In these experiments, we quantified the relative gene expression of CRH from extracted 
hypothalamus and hippocampus. It is widely known that CRH is released from the PVN of the 
hypothalamus, however, when the hippocampus is exposed to CORT, hippocampal neurons, 
particularly those in the CA1 and CA3, also release CRH173. Previous preliminary data indicated 
that circulating CORT was lower, but not quite significant in males in our laboratory’s studies. 
However in a lateral model of FPI, basal levels of CORT at 7 DPI were significantly lower than 
shams174. With a decrease in CORT and a decreased expression of GR in males, there is a 
decrease of negative feedback for CRH. Therefore, we hypothesized that CRH would be higher in 
the injured animals in both males but not in females. 
 
There were no significant differences in relative CRH gene expression in either the hypothalamus 
or hippocampus. My hypothesis was not supported by relative CRH gene expression.  
 
 
Figure 18 Relative Gene Expression Analysis of CRH. A) and B) There Were No Significant Differences in 
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11.0 DISCUSSION 
The purpose of this project was to evaluate neuroinflammation in an area with no quantifiable 
neuropathology and an area with neuropathology in the HPA axis and determine if GR levels 
were changing in those regions, providing evidence that GR expression may be driving microglial 
activation after TBI. Therefore, these experiments were designed to test the hypothesis that 
diffuse experimental TBI incites sexual differences in the HPA axis, influencing 
hypothalamic and hippocampal microglia presentation as well as glucocorticoid receptor 
levels at 7 DPI.  
 
11.1 Summary of Results  
Table 3 Summary of Results for The Hypothalamus. Microglia Presentation and Activation Is Indicative of 
Inflammation in Males, but Not in Females. There Were No Significant Changes in GR Gene Expressions in 
Males or Females. GR Protein Expression Significantly Decreased in Males, Yet Significantly Increased in 
Females.  
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Table 4 Summary of Results for the Hippocampus. Microglia Presentation and Activation is Indicative of 
Inflammation in Males and Females, with Microglia Presentation Being Greater in Males Than in Females. 
There Were No Significant Differences in GR Gene Expression. GR Protein Expression Significantly 
Decreased in Males, but Not Females. Sham Females Expressed Significantly Less GR Protein Than Sham 
Males. 
 
We found significant increases in PVN microglia cell number and decreases in endpoint/cell and 
branch length per cell in males, which is indicative of microglia morphology during 
neuroinflammation. We saw no significant differences in females, but also saw no interaction 
between sex and injury in our two-way ANOVA. See Table 3. In 2016, Rowe et.al published that 
males did not indicate any quantifiable pathology in the PVN at 7 DPI, suggesting that another 
mechanism may influence microglia activation in the PVN, possibly through GR-related 
mechanisms175.  
 
In the dentate gyrus, an area of overt neuropathology, we found a significant increase in microglia 
cell numbers in both injured male and injured females compared to respective shams, however, 
injured males had significantly more microglia cell numbers than injured females. Both injured 
males and injured females had a significant decrease in endpoints/cell and injured males had a 
significant decrease in branch length/cell. A two-way ANOVA indicated an interaction between 
sex and injury, with a main effect that sex influences injury outcome See Table 4.  
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There are few studies that have evaluated microglia and females. In this study, activated 
microglial presentation differed between males and females, where both showed evidence of 
microglial activation – where males responded more than females. Mechanisms that could be 
mediating this difference have been indicated by sex-specific genes and possibly maintained by 
circulating sex hormones, including 17β-estradiol176. Another study indicated that naïve males 
exhibited an increased amount of phagocytotic activity compared to naïve females; while naïve 
females secreted higher levels of IL-1β and TNF-α compare to naïve males. In another model of 
TBI (CCI), Villapol et al. demonstrated that neuroinflammation in males is much greater than 
females, not only in the dentate gyrus, but also in a the cortex and thalamus166. In the cortex, 
Villapol et al. found that females exhibited an increase in activated microglia morphology (ramified 
with rough prolongations) at 4h, 1 DPI, and 30 DPI, where males predominantly exhibited 
amoeboid microglia until 3 DPI. Also, at 1 DPI in CCI, injured males exhibited an increase of 
peripheral myeloid cells (precursor cells; amoeboid morphology) followed by proliferation of 
resident microglia at 3 DPI, however female myeloid influx and microglia activation is 
diminished177. Villapol’s data was similar to our results in the dentate gyrus, where the number of 
microglia in males increased by 200% and females increased by 52%. In the hypothalamus, the 
number of microglia in males increased by 33%, while no differences were discovered in females. 
Amoeboid cells in the dentate gyrus were not evaluated in this study but could potentially also 
demonstrate sex-differences.  Together, these data compliment previously reported sex-
differences in neuroinflammatory response after brain injury.  
 
Estrogen and progesterone178, 179 are noted to play a protective role against injury including 
decreasing neuroinflammation in the brain as a whole107. In a stroke model, when males were 
given a 17β-estradiol and progesterone treatment after stroke, microglia activation and lessen 
proinflammatory cytokine release180. The literature suggests that differences in circulating 
estradiol, ILs, and myeloid cells could have contributed to the differences observed in this study.  
A limitation of this study did is we did not track female estrous cycles, as menstrual cycle might 
influence outcome of TBI150, 181, potentially adding variability to data from females.  
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The changes in microglia presentation and activation in both the PVN and dentate gyrus indicate 
that TBI influences inflammation in the HPA axis at 7 DPI. Additionally, the dentate gyrus has 
overt neuropathology, however as previously stated, the PVN does not. These data led us to 
evaluate GR gene and protein expression in both regions. In the hypothalamus, male GR protein 
expression decreased while female GR protein expression increased, however there were no 
changes in gene expression. In the hippocampus, GR protein expression is decreased in injured 
males, but no differences in gene expression. There are no differences in GR gene expression or 
protein expression in females. These data indicate that other mechanisms may be regulating 
protein expression downstream from gene transcription. Additionally, these data support the 
notion that males and females respond to TBI differently.  
 
In the hypothalamus, there are differences between gene expression and protein expression in 
both sexes, but in the hippocampus when gene expression decreases, protein expression 
decreases and when gene expression stays constant, protein expression stays constant. Vogel 
and Marcotte (2012) explain that, in a homeostatic steady state, mRNA and protein expression 
only correlate about one to two thirds of the time, depending on the organism, however studies 
attempting to investigate the correlation in disrupted states, have acquired conflicting results182. 
Additionally, when CORT is low, GR’s will downregulate their receptors through reduced mRNA 
transcription, protein degradation, ubiquitin-dependent degradation, receptor inactivation or 
modifications183 CORT is low in males 7 DPI, if GRs are reduced by degradation or inactivation, 
may explain why our data indicated no changes in gene expression but decreases in protein 
expression .  
 
Literature suggests that GR expression in the HPA axis is critical for CORT regulation and 
affective disorder management. Decreased GR expression in the hypothalamus is associated 
with higher levels of circulating CORT, indicative of HPA axis dysregulation184. Decreased GR 
expression in the hippocampus is associated with increased affective disorders81, 185. 
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Understanding how TBI affects GR receptors post-injury and thus how GRs influence HPA axis 
regulation can help provide therapeutic targets for clinical treatment.  
 
In normal conditions, CORT binds to GRs in the PVN which slows CRH release – a standard 
negative feedback loop. Other models of TBI in males indicate acute increases in CORT and 
CRH. For at least 6 hours after experimental TBI, CORT is increased186, 187, then decreases for 
up to 7 DPI before slowly increasing at 14 DPI174. However, our model of TBI indicates that in 
males, CORT is decreased at 54 DPI, suggesting long-term HPA axis dysregulation162. 
Concurrently, CRH levels increase for up to 4 hours post-injury188. The mechanisms behind the 
acute CRH increase are still unclear.  
 
At 7 DPI CORT is dysregulated in the CCI model174 – and is trending towards a decrease in 
males with no change in females in our preliminary data in mFPI. While our data indicates 
downregulated GRs in males and upregulated GRs in females, CRH gene expression showed no 
significant differences in either males or females. It is expected that CRH expression would not 
change in females, as GR levels did not change. However, in males, this could be indicative of 
another influencing mechanism. CRH is also regulated by diurnal rhythms through MR’s and may 
possibly reach homeostasis. However, dysregulation can occur downstream with ACTH in the 
pituitary. As previously stated, DAI causes circuit disruption between the hypothalamus and 
pituitary, leading to the increase in risk for hypopituitarism111 and ACTH deficiencies189.  An ACTH 




11.2 Future Studies and Implications 
TBIs are not solely mechanical events, but rather, they are a complex cascade of molecular 
mechanisms that involve several intertwining systems. TBI incites neuroinflammation, which, if 
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left unattenuated, can become neurotoxic. Stress, environmental or physiological, has also been 
shown to incite neuroinflammation. What occurs when TBI and stress are combined?  
 
This project was designed to provide the answers to basic questions before more complex 
studies could be designed. The next step is to conduct colocalization of GRs on microglia in the 
hypothalamus and dentate gyrus. The dentate gyrus was chosen for SA as it is the brain region 
with most dense concentration of GRs next to the PVN. However, biopsies contained the entire 
anterior hippocampus. Colocalization will determine if GR levels are changing on microglia in the 
PVN and dentate gyrus specifically.  
 
Glucocorticoids receptors have many different isoforms as a result of mRNA alternative splicing: 
GRα and GRβ. GRα is the most expressed of the GR isoforms190. Little is known about the 
functions and expression levels of GRβ, however there is evidence that GRβ contributes to 
glucocorticoid resistance. When CORT binds to GRβ, it increases GR resistance 10 and can also 
up-regulate Toll-like Receptor 2/4 (TLR2/4)40 which increases microglia activation41. Future 
studies are needed to determine which isoform has increased expression. It is expected that with 
an increase in inflammation but a decrease in GR protein expression, that the GR isoforms 
remaining are GRβ.  
 
This project used previously harvested tissue. During tissue collection, rats of the same cage 
were live decapitated with a two-minute lapse between rats. CORT rises after 4 minutes of 
disturbance from the home-room. The second animal may have had yielded atypical results. As 
such, we have amended our protocol to reflect home-room to live decapitation under 4 minutes 
for both rats in the cage. We are currently expanding our animal numbers all groups for the later 
time points.  
This study is among the first to investigate sex differences in the HPA axis after TBI. Further, 
there is a paucity of information on how estrous cycle influences general injury outcomes. 
However, the estrous cycle has been reported to influence CORT levels, GR expression, 
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neurological outcomes after injury (in humans)108, 150, 152, 191. Future translational experiments 
would do well to track estrous, which may possibly explain why the outcome measures between 
female sham and injured rats differed in comparison to male sham and injured rats. Additionally, it 
would be beneficial to add a behavioral component for anxiety, such as the open field test, as 
several studies report that women are more likely to have continuing symptoms of anxiety and 




The HPA axis is a highly regulated system and disruption of that system provokes several 
hormone imbalances that can contribute to reported endocrinopathies as well as persisting 
anxiety and/or stress disorders. Taken together, these data indicate HPA axis dysregulation after 
TBI at 7 DPI in males and females. Further investigation is needed into the mechanism behind 
microglia presentation in the PVN in males and the GR isoform presentation on microglia in both 
the PVN and dentate gyrus. Additionally, further investigation is needed into the mechanisms 
behind the sexual differences in inflammation and GR expression between males and females. 
These data are among the first in the field to look at females and the HPA axis after injury and as 
such will serve as a launchpad for future, mechanistic experiments.   
 
Most importantly, these data are clinically translational and can be applied to patient care. 
Patients who sustain a DAI have an abrupt increase in CORT levels, taken together, these data 
can help physicians asses treatment plans based on the fundamental knowledge of how 
inflammation increases in males verses females and how the HPA axis dysregulates over the first 
week of injury. Translational research is imperative as it increases the standard for personalized 
medicine, increasing the quality of life for each individual patient. 
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Optimization of Qiagen DNA/RNA/Protein Protocol  
Homogenization: 
1. Add 1ul of BME to 100ul of Buffer RTL in a fume hood (can store up to 1 month) 
2. In a 2mL tube, add 600ul of Buffer RLT 
 
#Samples ______ + 1 _____ X 600ul of Buffer RLT/BME = _________ Total ul 
 
1:100 ratio "#$	&'("))	#$	*+,	 	= 	 ._________________ 100𝑥 =	 ___       𝑥 =  
 
3. Transfer sample to tube with buffer 
4. Use homogenizer to homogenize sample (2 minutes) 
 
Procedure - RNA is centrifuged at 4C; protein at 13C 
1. Centrifuge the lysate for 3 min at full speed  
2. Remote the supernatant and transfer to an AllPrep DNA spin column/collection tube 
3. Centrifuge for 30 seconds at 8000g. Repeat. Discard (not using DNA).  
RNA Protocol 
1. Take the flow-through from previous step and add 430ul of 100% ethanol. Mix well by 
pipetting.  
2. Transfer 700 μl of the sample to an RNeasy spin column placed in a 2 ml collection tube. 
3. Centrifuge for 15 seconds at 8000g 
4. Transfer the flow-through to a 2 ml tube for protein purification. Repeat and flow-through 
on ice. 
5. Add 700 μl Buffer RW1 to the RNeasy spin column 
6. Centrifuge for 30 seconds at 8000g. Discard the flow-through 
7. Add 500 μl Buffer RPE to the RNeasy spin column.  
8. Centrifuge for 30 seconds at 8000g. Discard the flow-through 
9. Add 500 μl Buffer RPE to the RNeasy spin column 
10. Centrifuge for 1 minutes at 8000g 
11. Add 500 μl of 80% EtOH to the RNeasy spin column 
12. Centrifuge for 2 minutes at 8000g 
13. Place the RNeasy spin column in a new 2 ml collection tube and discard the old collection 
tube with the flow-through. Leave lid open. Centrifuge at full speed for 5 min. 
14. Place the RNeasy spin column in a new 1.5 ml collection tube. Add 30 μl RNase-free water 
directly to the spin column membrane. Centrifuge for 1 minute at 8000g to elute RNA. 
15. Do Nano-drop à then place on ice/freeze at -80 until can do cDNA steps.  
 
Sample Ng/ul 260/280 ratio 
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Total Protein Precipitation Protocol 
1.  Take flow through from RNA Step 4 and add 600ul of Buffer APP. Mix vigorously and 
incubate at room temperature for 10 min to precipitate protein. 
2. Centrifuge at full speed for 10 min.  
3. Carefully decant the supernatant. 
4. Add 500 μl of 70% ethanol to the protein pellet. 
5. Centrifuge at full speed for 1 min.  
6. Remove the supernatant by using a pipet or by decanting as much liquid as possible. 
7. Dry the protein pellet for 10 min at room temperature. 
8. Add up to 100 μl SDS and mix vigorously to dissolve the protein pellet. Vortex for several 
minutes or disaggregate the pellet by pipetting up and down several times. 
9. Incubate for 5 min at 95°C to completely dissolve and denature protein. Then cool the sample 
to room temperature. 
10. Centrifuge for 1 min at full speed to pellet any residual insoluble material. 
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DATA COLLECTED JANUARY 2019 – JULY 2019 
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20/80 Optimization 
The original study design included time points at 56 and 168 DPI, however, original samples from 
the 2017 study were stored incorrectly. Almost half of the brain punches of 56 and 168 DPI 
samples were stored, either entirely or temporarily, in -20°C conditions. As the length of time the 
samples were -20°C conditions were unknown, and the total effect on qPCR and protein analysis 
was unknown, I ran several samples through the full protocol. For samples stored in the -80°C, 
the average ng/ul was ~90 and the 260/280 ratio average was ~2.02. For samples stored in the -
20°C, average ng/ul was ~15 and the 260/280 ratio average was ~1.88. Protein concentration 
values on the BCA assay were inconsistent and not associated to freezer storage. However, the 
protein assay showed many inconsistencies, including atypical protein levels and atypical protein 
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APPENDIX D 
 
DATA COLLECTED JANUARY 2019 – JULY 2019 
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Wes Plate Design 
 
 
 
